Stock AMBEA AMBEA AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ambea AB

Equities

AMBEA

SE0009663826

Healthcare Facilities & Services

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:49 2024-04-26 am EDT 		5-day change 1st Jan Change
63.4 SEK +1.93% Intraday chart for Ambea AB -0.86% +20.53%
Apr. 12 Ambea AB Proposes Dividend, Payable on 22 May 2024 CI
Mar. 13 Triton Fund III-controlled ACTR Trims Ambea Shareholding via Share Placement MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 7,419 6,148 5,715 4,161 4,711 5,678 - -
Enterprise Value (EV) 1 15,336 14,524 15,536 14,879 15,450 16,202 15,701 14,527
P/E ratio 31.2 x 17.1 x 24.1 x 11.3 x 10.4 x 11.3 x 9.23 x 7.66 x
Yield - 1.77% 1.9% 2.84% 2.38% 2.59% 3.14% 3.71%
Capitalization / Revenue 0.67 x 0.55 x 0.5 x 0.33 x 0.35 x 0.41 x 0.39 x 0.38 x
EV / Revenue 1.39 x 1.31 x 1.35 x 1.18 x 1.16 x 1.16 x 1.08 x 0.97 x
EV / EBITDA 10.2 x 8.73 x 8.66 x 7.28 x 6.78 x 6.62 x 6.07 x 5.33 x
EV / FCF -8.8 x 12.5 x 13.6 x 10.3 x 9.47 x 11.3 x 10.1 x 8.78 x
FCF Yield -11.4% 8.03% 7.33% 9.75% 10.6% 8.87% 9.86% 11.4%
Price to Book 1.84 x 1.42 x 1.26 x 0.89 x 0.96 x 1.08 x 0.99 x 0.89 x
Nbr of stocks (in thousands) 94,505 94,437 94,302 94,533 89,563 89,563 - -
Reference price 2 78.50 65.10 60.60 44.02 52.60 63.40 63.40 63.40
Announcement Date 2/14/20 2/16/21 2/9/22 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 11,040 11,083 11,478 12,635 13,312 13,909 14,506 14,992
EBITDA 1 1,508 1,663 1,794 2,044 2,278 2,446 2,586 2,726
EBIT 1 525 717 743 843 981 1,092 1,195 1,333
Operating Margin 4.76% 6.47% 6.47% 6.67% 7.37% 7.85% 8.24% 8.89%
Earnings before Tax (EBT) 1 276 457 297 482 565 624.9 761.6 916.4
Net income 1 215 359 237 366 455 487.3 594.5 716.3
Net margin 1.95% 3.24% 2.06% 2.9% 3.42% 3.5% 4.1% 4.78%
EPS 2 2.520 3.800 2.510 3.890 5.070 5.605 6.868 8.274
Free Cash Flow 1 -1,743 1,166 1,139 1,451 1,631 1,438 1,548 1,656
FCF margin -15.79% 10.52% 9.92% 11.48% 12.25% 10.33% 10.67% 11.04%
FCF Conversion (EBITDA) - 70.11% 63.49% 70.99% 71.6% 58.78% 59.83% 60.72%
FCF Conversion (Net income) - 324.79% 480.59% 396.45% 358.46% 295.02% 260.3% 231.1%
Dividend per Share 2 - 1.150 1.150 1.250 1.250 1.645 1.991 2.350
Announcement Date 2/14/20 2/16/21 2/9/22 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2,912 2,988 3,080 3,143 3,187 3,225 3,235 3,310 3,355 3,412 3,424 3,479 3,460 3,538 3,530
EBITDA 1 578 492 451 511 634 447 510 485 693 591 564.5 550 724.5 607 572
EBIT 1 316 182 167 202 333 140 191 167 360 264 233.5 219.5 390 274.5 241
Operating Margin 10.85% 6.09% 5.42% 6.43% 10.45% 4.34% 5.9% 5.05% 10.73% 7.74% 6.82% 6.31% 11.27% 7.76% 6.83%
Earnings before Tax (EBT) 1 240 -49 83 117 249 33 89 59 261 157 114 99 270 158.5 126
Net income 1 190 -37 66 86 193 22 70 46 206 133 88 76.5 212 123.5 97
Net margin 6.52% -1.24% 2.14% 2.74% 6.06% 0.68% 2.16% 1.39% 6.14% 3.9% 2.57% 2.2% 6.13% 3.49% 2.75%
EPS 2 2.010 -0.3900 0.7000 0.9100 2.040 0.2400 0.7700 0.5100 2.300 1.480 1.000 0.8850 2.450 1.425 1.120
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/9/22 5/4/22 8/18/22 11/3/22 2/9/23 5/4/23 8/17/23 11/2/23 2/8/24 - - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 7,917 8,376 9,821 10,718 10,739 10,524 10,023 8,849
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5.25 x 5.037 x 5.474 x 5.244 x 4.714 x 4.303 x 3.875 x 3.246 x
Free Cash Flow 1 -1,743 1,166 1,139 1,451 1,631 1,438 1,548 1,656
ROE (net income / shareholders' equity) 6.4% 8.59% 5.35% 7.95% 9.48% 9.96% 11.5% 12.2%
ROA (Net income/ Total Assets) 2.19% 2.52% 1.51% 2.12% 2.54% 2.8% 3.42% 3.94%
Assets 1 9,817 14,264 15,696 17,275 17,884 17,384 17,396 18,198
Book Value Per Share 2 42.70 45.80 47.90 49.70 54.80 58.90 64.20 71.00
Cash Flow per Share 11.40 13.60 12.80 15.30 - - - -
Capex 1 111 112 131 105 90 124 134 140
Capex / Sales 1.01% 1.01% 1.14% 0.83% 0.68% 0.89% 0.93% 0.94%
Announcement Date 2/14/20 2/16/21 2/9/22 2/9/23 2/8/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Ambea AB

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
63.4 SEK
Average target price
79.67 SEK
Spread / Average Target
+25.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
AMBEA AB Stock Ambea AB
+20.53% 518M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. AMBEA Stock
  4. Financials Ambea AB